5Lansberg MG,Schrooten M, Bluhmki E,et al. Treatmenttime. Specific number needed to treat estimates for tissueplasminogen activator therapy in acute stroke based on shiftsover the entire range ofthe modified rankin scale[J]. Stroke*2009,40(6):2079-2084.
6Fonarow GC,Smith EE,Saver JL,et al. Timeliness of tissue.Type plasminogen activator therapy in acute ischemic stroke:patient characteristics,hospital factors,and outcomes associat-ed with doorto needle times within 60 minutes[J]. Circulation,2011,123(7):750-758.